[ad_1] Caltech AI professor and biotech veterans secure $13M in venture capital to create new category of biologic medicine SAN DIEGO, Nov. 21, 2024 /PRNewswire/ — Aizen Therapeutics, an AI-driven biotechnology company, today emerged from […]
Tag: Biotechnology
Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
[ad_1] Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2+ BTC in the U.S. Ziihera received accelerated approval based on results including a 52% objective response rate and median duration of […]
BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
[ad_1] Management to Hold Conference Call at 8:30 a.m. EST TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and […]
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset
[ad_1] STATEN ISLAND, N.Y., Nov. 20, 2024 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“we” or “Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the […]
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
[ad_1] Ampersand’s AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets Montai’s CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related […]
